The U.S. Food and Drug Administration is investigating whether Fresenius Medical Care, a German-based company that operates and supplies dialysis centers, sat on information suggesting that one of its products carries a potentially lethal risk, according to the New York Times.
Fresenius treats more than a third of the estimated 400,000 Americans who receive dialysis, and is also the country’s leading supplier of dialysis machines and disposable products. It maintains its own clinics, and provides products for other clinics as well.
Last ...
continue reading...
